Full-year Financial Statements 2006/07

 | Source: Coloplast A/S Coloplast A/S 

Coloplast met expectations for growth for the 2006/07 financial year, reporting
organic revenue growth of 10% against 8% last year. The company maintained the
EBIT margin before non-recurring costs at 16% in a year dominated by extensive
activity of integrating the acquired urology business, divesting businesses and
relocating production to Hungary and China. EBIT was DKK 749m after
non-recurring costs of DKK 552m, which included a goodwill writedown of DKK
283m (see enclosed PDF).

Attachments

fbm_2007_q4_final_uk.pdf
GlobeNewswire

Recommended Reading